Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/1765
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technology-
dc.creatorChan, ASC-
dc.creatorChen, G-
dc.creatorGuo, R-
dc.creatorWu, J-
dc.date.accessioned2010-03-22T08:31:12Z-
dc.date.available2010-03-22T08:31:12Z-
dc.identifier.urihttp://hdl.handle.net/10397/1765-
dc.language.isoenen_US
dc.rightsAssignee: The Hong Kong Polytechnic University.en_US
dc.titleChiral tertiary aminoalkylnaphtholsen_US
dc.typePatenten_US
dc.description.otherinformationUS7674900; US7674900 B2; US7674900B2; US7,674,900; US 7,674,900 B2; 7674900; Appl. No. 11/578,708en_US
dcterms.abstractThe present invention provides bipyrimidinyl diphosphine compounds of the formula [refer to Patent file] (I) wherein R is optionally substituted alkyl, cycloalkyl, aryl or heteroaryl; R' and R'' are independently optionally substituted alkyl, cycloalkyl, aryl or heteroaryl; or an enantiomer thereof; or an enantiomeric mixture thereof. The compounds of the formula (I) are chiral atropisomeric bipyrimidinyl diphosphine compounds and, thus, may be employed as ligands to generate chiral transition metal catalysts which may be applied in a variety of asymmetric reactions, e.g., in palladium catalyzed asymmetric allylic substitution reactions. The compounds of the present invention are easily accessible in high enantiomeric purity according to the methods disclosed herein.-
dcterms.bibliographicCitationUS Patent 7,674,900 B2. Washington, DC: US Patent and Trademark Office, 2010.-
dcterms.issued2010-03-09-
dc.description.countryUS-
dc.description.oaVersion of Recorden_US
Appears in Collections:Patent
Files in This Item:
File Description SizeFormat 
us7674900b2.pdf350.12 kBAdobe PDFView/Open
Show simple item record

Page views

97
Last Week
1
Last month
Citations as of Apr 14, 2024

Downloads

27
Citations as of Apr 14, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.